{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:04:27Z","timestamp":1789103067663,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10430 01 201 0021"],"award-info":[{"award-number":["10430 01 201 0021"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012023","name":"Stichting Sanquin Bloedvoorziening","doi-asserted-by":"publisher","award":["PPOC 19\u201308"],"award-info":[{"award-number":["PPOC 19\u201308"]}],"id":[{"id":"10.13039\/501100012023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012023","name":"Stichting Sanquin Bloedvoorziening","doi-asserted-by":"publisher","award":["SQI00041"],"award-info":[{"award-number":["SQI00041"]}],"id":[{"id":"10.13039\/501100012023","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ebiom.2022.104109","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T14:07:20Z","timestamp":1655906840000},"page":"104109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Immunoassay for quantification of antigen-specific IgG fucosylation"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0559-6803","authenticated-orcid":false,"given":"Ton\u0107i","family":"\u0160u\u0161ti\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Van Coillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads Delbo","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninotska I.L.","family":"Derksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Szittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Nouta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timon","family":"Damelang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6031-0081","authenticated-orcid":false,"given":"Ianthe","family":"Rebergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Linty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juk Yee","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionne M.","family":"Geerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim J.E.","family":"van Esch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"de Taeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit J.","family":"van Gils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"van de Watering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ellen","family":"van der Schoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Rispens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-003X","authenticated-orcid":false,"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2022.104109_bib0001","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"issue":"5753","key":"10.1016\/j.ebiom.2022.104109_bib0002","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin g subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104109_bib0003","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3389\/fimmu.2019.02237","article-title":"Genetic variation in low-to-medium-affinity fcgamma receptors: functional consequences, disease associations, and opportunities for personalized medicine","volume":"10","author":"Nagelkerke","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104109_bib0004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0036-1584322","article-title":"The immunobiology of immunoglobulin G4","volume":"36","author":"Lighaam","year":"2016","journal-title":"Semin Liver Dis"},{"issue":"5787","key":"10.1016\/j.ebiom.2022.104109_bib0005","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"issue":"6027","key":"10.1016\/j.ebiom.2022.104109_bib0006","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/316452a0","article-title":"Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG","volume":"316","author":"Parekh","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104109_bib0007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The impact of glycosylation on the biological function and structure of human immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ebiom.2022.104109_bib0008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","article-title":"Immunoglobulin G glycosylation in aging and diseases","volume":"333","author":"Gudelj","year":"2018","journal-title":"Cell Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104109_bib0009","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbagen.2007.06.012","article-title":"The N-linked sugar chains of human immunoglobulin G: their unique pattern, and their functional roles","volume":"1780","author":"Kobata","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"30","key":"10.1016\/j.ebiom.2022.104109_bib0010","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104109_bib0011","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity","volume":"278","author":"Shinkawa","year":"2003","journal-title":"J Biol Chem"},{"issue":"31","key":"10.1016\/j.ebiom.2022.104109_bib0012","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1073\/pnas.1108455108","article-title":"Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose","volume":"108","author":"Ferrara","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104109_bib0013","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1021\/acschembio.8b00342","article-title":"Antibody fucosylation lowers the FcgammaRIIIa\/CD16a affinity by limiting the conformations sampled by the N162-Glycan","volume":"13","author":"Falconer","year":"2018","journal-title":"ACS Chem Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104109_bib0014","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1982847","article-title":"Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography-mass spectrometry","volume":"13","author":"Lippold","year":"2021","journal-title":"MAbs"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104109_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nbt1178","article-title":"Optimization of humanized IgGs in glycoengineered Pichia pastoris","volume":"24","author":"Li","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"2\u20133","key":"10.1016\/j.ebiom.2022.104109_bib0016","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clim.2005.10.008","article-title":"Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions","volume":"118","author":"Siberil","year":"2006","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104109_bib0017","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1158\/2326-6066.CIR-14-0125","article-title":"Afucosylated antibodies increase activation of FcgammaRIIIa-dependent signaling components to intensify processes promoting ADCC","volume":"3","author":"Liu","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ebiom.2022.104109_bib0018","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fimmu.2017.00877","article-title":"Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities","volume":"8","author":"Dekkers","year":"2017","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104109_bib0019","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.4049\/jimmunol.1900985","article-title":"Functional attributes of antibodies, effector cells, and target cells affecting NK Cell-mediated antibody-dependent cellular cytotoxicity","volume":"203","author":"Temming","year":"2019","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104109_bib0020","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1080\/19420862.2016.1218586","article-title":"The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc gamma receptor","volume":"8","author":"Subedi","year":"2016","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104109_bib0021","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1893427","article-title":"Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation","volume":"13","author":"Wei","year":"2021","journal-title":"MAbs"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104109_bib0022","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.2100399","article-title":"Fc Galactosylation promotes hexamerization of human IgG1, leading to enhanced classical complement activation","volume":"207","author":"van Osch","year":"2021","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104109_bib0023","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1021\/acs.jproteome.6b00038","article-title":"Changes in healthy human IgG Fc-glycosylation after birth and during early childhood","volume":"15","author":"de Haan","year":"2016","journal-title":"J Proteome Res"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104109_bib0024","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104109_bib0025","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/bjh.12965","article-title":"Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn","volume":"166","author":"Kapur","year":"2014","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104109_bib0026","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/bjh.14053","article-title":"Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia","volume":"174","author":"Sonneveld","year":"2016","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104109_bib0027","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1021\/pr800651j","article-title":"Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens","volume":"8","author":"Wuhrer","year":"2009","journal-title":"J Proteome Res"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104109_bib0028","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/trf.12880","article-title":"Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D","volume":"55","author":"Kapur","year":"2015","journal-title":"Transfusion"},{"issue":"6323","key":"10.1016\/j.ebiom.2022.104109_bib0029","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.aai8128","article-title":"IgG antibodies to dengue enhanced for FcgammaRIIIA binding determine disease severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"issue":"6546","key":"10.1016\/j.ebiom.2022.104109_bib0030","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1126\/science.abc7303","article-title":"Antibody fucosylation predicts disease severity in secondary dengue infection","volume":"372","author":"Bournazos","year":"2021","journal-title":"Science"},{"issue":"6532","key":"10.1016\/j.ebiom.2022.104109_bib0031","doi-asserted-by":"crossref","first-page":"8378","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104109_bib0032","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","article-title":"Proinflammatory IgG Fc structures in patients with severe COVID-19","volume":"22","author":"Chakraborty","year":"2021","journal-title":"Nat Immunol"},{"issue":"596","key":"10.1016\/j.ebiom.2022.104109_bib0033","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1126\/scitranslmed.abf8654","article-title":"High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages","volume":"13","author":"Hoepel","year":"2021","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104109_bib0034","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104109_bib0035","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1038\/s41467-021-26118-w","article-title":"Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination","volume":"12","author":"Larsen","year":"2021","journal-title":"Nat Commun"},{"issue":"22","key":"10.1016\/j.ebiom.2022.104109_bib0036","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1002\/pmic.200700289","article-title":"Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum","volume":"7","author":"Wuhrer","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.ebiom.2022.104109_bib0037","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4939-6493-2_4","article-title":"High-throughput analysis of IgG Fc glycopeptides by LC-MS","volume":"1503","author":"Falck","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104109_bib0038","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","article-title":"Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities","volume":"151","author":"Gonzalez-Quintela","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ebiom.2022.104109_bib0039","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molimm.2017.12.006","article-title":"Conserved FcgammaR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice","volume":"94","author":"Dekkers","year":"2018","journal-title":"Mol Immunol"},{"issue":"6504","key":"10.1016\/j.ebiom.2022.104109_bib0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104109_bib0041","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/19420862.2017.1323159","article-title":"Affinity of human IgG subclasses to mouse Fc gamma receptors","volume":"9","author":"Dekkers","year":"2017","journal-title":"MAbs"},{"key":"10.1016\/j.ebiom.2022.104109_bib0042","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fimmu.2020.00740","article-title":"FcgammaR Binding and ADCC Activity of Human IgG Allotypes","volume":"11","author":"de Taeye","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2022.104109_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.594773","article-title":"C-Reactive protein enhances IgG-mediated cellular destruction through IgG-Fc receptors in vitro","volume":"12","author":"Temming","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104109_bib0044","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymeth.2013.07.018","article-title":"A simple, robust and highly efficient transient expression system for producing antibodies","volume":"65","author":"Vink","year":"2014","journal-title":"Methods"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104109_bib0045","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104109_bib0046","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.4049\/jimmunol.2000767","article-title":"Development of a SARS-CoV-2 total antibody assay and the dynamics of antibody response over time in hospitalized and nonhospitalized patients with COVID-19","volume":"205","author":"Vogelzang","year":"2020","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104109_bib0047","doi-asserted-by":"crossref","first-page":"e1285","DOI":"10.1002\/cti2.1285","article-title":"Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors","volume":"10","author":"Steenhuis","year":"2021","journal-title":"Clin Transl Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104109_bib0048","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/19420862.2018.1466767","article-title":"The \u201cless-is-more\u201d in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity","volume":"10","author":"Pereira","year":"2018","journal-title":"MAbs"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104109_bib0049","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10719-022-10044-0","article-title":"Antibody glycosylation in COVID-19","volume":"39","author":"Pongracz","year":"2022","journal-title":"Glycoconj J"},{"key":"10.1016\/j.ebiom.2022.104109_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103957","article-title":"Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19","volume":"78","author":"Pongracz","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104109_bib0051","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4049\/jimmunol.1700116","article-title":"Enhanced effector functions due to antibody defucosylation depend on the effector cell fcgamma receptor profile","volume":"199","author":"Bruggeman","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2022.104109_bib0052","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fimmu.2018.00129","article-title":"Fc-Glycosylation in human IgG1 and IgG3 is similar for both total and anti-red-blood cell anti-K antibodies","volume":"9","author":"Sonneveld","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104109_bib0053","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4161\/mabs.26307","article-title":"Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity","volume":"5","author":"Shatz","year":"2013","journal-title":"MAbs"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104109_bib0054","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/s41591-021-01488-2","article-title":"Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial","volume":"27","author":"Begin","year":"2021","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104109_bib0055","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201993","article-title":"Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo","volume":"218","author":"Schafer","year":"2021","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104109_bib0056","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4049\/jimmunol.1502551","article-title":"Dimeric FcgammaR ectodomains as probes of the Fc receptor function of anti-influenza virus IgG","volume":"197","author":"Wines","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2022.104109_bib0057","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2017.01.010","article-title":"Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles","volume":"443","author":"Brown","year":"2017","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104109_bib0058","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41467-021-22236-7","article-title":"Systems serology detects functionally distinct coronavirus antibody features in children and elderly","volume":"12","author":"Selva","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2022.104109_bib0059","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jim.2019.05.006","article-title":"A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis","volume":"471","author":"Karsten","year":"2019","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104109_bib0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12865-022-00480-w","article-title":"Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2","volume":"23","author":"Natarajan","year":"2022","journal-title":"BMC Immunol"},{"issue":"16","key":"10.1016\/j.ebiom.2022.104109_bib0061","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:19:39Z","timestamp":1762456779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422002900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":61,"alternative-id":["S2352396422002900"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104109","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoassay for quantification of antigen-specific IgG fucosylation","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104109"}}